Phibro Animal Health | PAHC - Créances Commerciales





Créances Commerciales Changement Date
Align Technology USD 1.16B 15.46M 2026-09
ANI Pharmaceuticals USD 304.45M 29.98M 2026-09
Aurora Cannabis CAD 41.09M 3.49M 2026-06
Bristol-Myers Squibb USD 12.85B 976M 2026-09
Canopy Growth CAD 42.59M 6.3M 2026-06
Corcept Therapeutics USD 111.06M 34.14M 2026-09
Eli Lilly USD 23.48B 2.3B 2026-06
Henry Schein USD 1.88B 112M 2026-09
Idexx Laboratories USD 615.8M 11.28M 2026-09
Knight Therapeutics CAD 183M 7.46M 2025-12
Merck USD 12.56B 354M 2026-06
Nektar Therapeutics USD 3.6M 1.82M 2026-03
Pacira USD 3.12B 2.99B 2026-09
Phibro Animal Health USD 215.87M 2.02M 2025-12
Prestige Brands USD 187.36M 4.56M 2026-06
Supernus Pharmaceuticals USD 211.66M 29.47M 2026-06
Zoetis USD 1.69B 121M 2026-09